Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

Jackson S., Marshall JL., Mawer A., Lopez-Ramon R., Harris SA., Satti I., Hughes E., Preston-Jones H., Cabrera Puig I., Longet S., Tipton T., Laidlaw S., Doherty RP., Morrison H., Mitchell R., Tanner R., Ateere A., Stylianou E., Wu M-S., Fredsgaard-Jones TPW., Breuer J., Rapeport G., Ferreira VM., Gleeson F., Pollard AJ., Carroll M., Catchpole A., Chiu C., McShane H., Alparaque M., Anid L., Barnes E., Benamore R., Bharti N., Patel B., Burns A., Byard N., Conway O., Cooper C., Crowther C., Dunachie SJ., Johnstone T., Jose J., Luciw M., Mujadidi Y., Nehiweze A., Nyamunda S., Orobiyi-Rieba M., Parvelikudy B., Platt A., Pswarayi D., Quaddy J., Samuel BE., Sette A., Sodipo V., Srijith P., Stone H., Turner C., Valmores MA., Voaides A., Vuddamalay G.

DOI

10.1016/s2666-5247(24)00025-9

Type

Journal article

Publisher

Elsevier BV

Publication Date

2024-07-01T00:00:00+00:00

Volume

5

Pages

655 - 668

Total pages

13

Permalink More information Close